Charles McNerney
Directeur/Membre du Conseil chez HAPBEE TECHNOLOGIES, INC.
Fortune : 56 250 $ au 30/06/2024
Profil
Charles E.
McNerney is currently serving as an Independent Director at Hapbee Technologies, Inc. since 2019 and at EMulate Therapeutics, Inc. since 2015.
Previously, he held the position of Chief Information Security Officer at Microsoft Corp.
from 1993 to 2019.
Additionally, he served as the Chief Information Security Officer & VP at Expedia Group, Inc. from 2019 to 2022.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/05/2024 | 450 000 ( 0,27% ) | 56 250 $ | 30/06/2024 |
Postes actifs de Charles McNerney
| Sociétés | Poste | Début |
|---|---|---|
| HAPBEE TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 22/05/2019 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Directeur/Membre du Conseil | 01/07/2015 |
Anciens postes connus de Charles McNerney
| Sociétés | Poste | Fin |
|---|---|---|
| EXPEDIA GROUP, INC. | Corporate Officer/Principal | 01/03/2022 |
| MICROSOFT CORPORATION | Corporate Officer/Principal | 01/11/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
| EXPEDIA GROUP, INC. | Consumer Services |
| MICROSOFT CORPORATION | Technology Services |
| Entreprise privées | 1 |
|---|---|
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
